Global PRRS Vaccines Market Growth 2025-2031
The global PRRS Vaccines market size is predicted to grow from US$ 420 million in 2025 to US$ 519 million in 2031; it is expected to grow at a CAGR of 3.6% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
There are two types of PRRS vaccines that are commercially available. One is a modified-live virus (MLV) vaccine and the other is a killed virus (KV) vaccine. PRRS MLV vaccine is well recognized for its protective efficacy against PRRSV that are genetically homologous to the vaccine virus.Porcine Reproductive and Respiratory Syndrome (PRRS) vaccine is a biological product designed to prevent and control PRRS, a highly contagious viral disease that affects pigs. The vaccine works by stimulating the pig's immune system to produce a protective response against the PRRS virus, thereby reducing reproductive failures such as abortions and stillbirths in sows, as well as respiratory illness and mortality in piglets and growing pigs. PRRS vaccines are typically classified into modified live vaccines (MLVs) and inactivated vaccines, and they play a critical role in improving herd health and productivity in the swine industry worldwide.
The global PRRS vaccine market is primarily driven by the widespread prevalence and economic impact of Porcine Reproductive and Respiratory Syndrome in the swine industry. PRRS is one of the most devastating diseases affecting pigs, causing significant reproductive losses in breeding herds and severe respiratory distress in growing pigs. The virus's ability to mutate and persist in herds has made it difficult to eradicate, leading to chronic infections and substantial financial losses for pig farmers. As a result, governments and veterinary authorities in major pork-producing countries such as China, the United States, and countries in the European Union have emphasized vaccination as a critical component of disease control programs. Additionally, rising global pork consumption is pressuring producers to maintain healthier herds and ensure consistent productivity, further boosting demand for effective PRRS vaccines. Technological advancements in vaccine formulation—such as the development of region-specific or genotype-specific modified live vaccines (MLVs)—have improved vaccine efficacy, making immunization a more reliable and widely accepted preventive measure. Moreover, increasing biosecurity awareness and the integration of vaccination into herd health management systems are reinforcing the growth of the PRRS vaccine market globally.
Despite its importance, the PRRS vaccine market faces several challenges that limit its effectiveness and adoption in certain regions. One of the primary issues is the virus's high genetic variability, which complicates the development of universally effective vaccines. The presence of multiple genotypes and frequent mutations means that vaccine strains may not provide cross-protection against all circulating variants, leading to inconsistent results and partial immunity in vaccinated herds. Additionally, modified live vaccines (MLVs), while generally more effective than inactivated ones, carry risks of reversion to virulence or recombination with field strains, which raises safety concerns among producers and regulatory bodies. In developing regions, limited access to veterinary services, cold chain logistics, and affordability issues further hinder the widespread adoption of PRRS vaccination programs. Moreover, there remains a lack of standardized vaccination protocols across countries, and vaccine performance can vary depending on farm conditions, pig genetics, and co-infections with other pathogens. These factors make disease management complex and can reduce confidence in vaccination strategies. Overcoming these challenges requires continued investment in research and development of next-generation vaccines, improved diagnostic tools for strain identification, and stronger government support for vaccination campaigns and swine health education.
LP Information, Inc. (LPI) ' newest research report, the “PRRS Vaccines Industry Forecast” looks at past sales and reviews total world PRRS Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected PRRS Vaccines sales for 2025 through 2031. With PRRS Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world PRRS Vaccines industry.
This Insight Report provides a comprehensive analysis of the global PRRS Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on PRRS Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global PRRS Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for PRRS Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global PRRS Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of PRRS Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global PRRS Vaccines market?
What factors are driving PRRS Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do PRRS Vaccines market opportunities vary by end market size?
How does PRRS Vaccines break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
There are two types of PRRS vaccines that are commercially available. One is a modified-live virus (MLV) vaccine and the other is a killed virus (KV) vaccine. PRRS MLV vaccine is well recognized for its protective efficacy against PRRSV that are genetically homologous to the vaccine virus.Porcine Reproductive and Respiratory Syndrome (PRRS) vaccine is a biological product designed to prevent and control PRRS, a highly contagious viral disease that affects pigs. The vaccine works by stimulating the pig's immune system to produce a protective response against the PRRS virus, thereby reducing reproductive failures such as abortions and stillbirths in sows, as well as respiratory illness and mortality in piglets and growing pigs. PRRS vaccines are typically classified into modified live vaccines (MLVs) and inactivated vaccines, and they play a critical role in improving herd health and productivity in the swine industry worldwide.
The global PRRS vaccine market is primarily driven by the widespread prevalence and economic impact of Porcine Reproductive and Respiratory Syndrome in the swine industry. PRRS is one of the most devastating diseases affecting pigs, causing significant reproductive losses in breeding herds and severe respiratory distress in growing pigs. The virus's ability to mutate and persist in herds has made it difficult to eradicate, leading to chronic infections and substantial financial losses for pig farmers. As a result, governments and veterinary authorities in major pork-producing countries such as China, the United States, and countries in the European Union have emphasized vaccination as a critical component of disease control programs. Additionally, rising global pork consumption is pressuring producers to maintain healthier herds and ensure consistent productivity, further boosting demand for effective PRRS vaccines. Technological advancements in vaccine formulation—such as the development of region-specific or genotype-specific modified live vaccines (MLVs)—have improved vaccine efficacy, making immunization a more reliable and widely accepted preventive measure. Moreover, increasing biosecurity awareness and the integration of vaccination into herd health management systems are reinforcing the growth of the PRRS vaccine market globally.
Despite its importance, the PRRS vaccine market faces several challenges that limit its effectiveness and adoption in certain regions. One of the primary issues is the virus's high genetic variability, which complicates the development of universally effective vaccines. The presence of multiple genotypes and frequent mutations means that vaccine strains may not provide cross-protection against all circulating variants, leading to inconsistent results and partial immunity in vaccinated herds. Additionally, modified live vaccines (MLVs), while generally more effective than inactivated ones, carry risks of reversion to virulence or recombination with field strains, which raises safety concerns among producers and regulatory bodies. In developing regions, limited access to veterinary services, cold chain logistics, and affordability issues further hinder the widespread adoption of PRRS vaccination programs. Moreover, there remains a lack of standardized vaccination protocols across countries, and vaccine performance can vary depending on farm conditions, pig genetics, and co-infections with other pathogens. These factors make disease management complex and can reduce confidence in vaccination strategies. Overcoming these challenges requires continued investment in research and development of next-generation vaccines, improved diagnostic tools for strain identification, and stronger government support for vaccination campaigns and swine health education.
LP Information, Inc. (LPI) ' newest research report, the “PRRS Vaccines Industry Forecast” looks at past sales and reviews total world PRRS Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected PRRS Vaccines sales for 2025 through 2031. With PRRS Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world PRRS Vaccines industry.
This Insight Report provides a comprehensive analysis of the global PRRS Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on PRRS Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global PRRS Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for PRRS Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global PRRS Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of PRRS Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Live Vaccines
- Killed Vaccines
- Government Tender
- Market Sales
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- China Animal Husbandry Co., Ltd.
- Boehringer Ingelheim
- MSD Animal Health
- Sinopharm Animal Health
- Ceva
- Ruipu Biological
- Qilu Animal Health
- Dahuanong
- CAVAC
- Komipharm
- Agrovet
- Bioveta
- Jinyu
- Phibro Animal Health
- Tiankang
- Zoetis
- Yongshun Biological
- Pulike Biological
What is the 10-year outlook for the global PRRS Vaccines market?
What factors are driving PRRS Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do PRRS Vaccines market opportunities vary by end market size?
How does PRRS Vaccines break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global PRRS Vaccines Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for PRRS Vaccines by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for PRRS Vaccines by Country/Region, 2020, 2024 & 2031
2.2 PRRS Vaccines Segment by Type
2.2.1 Live Vaccines
2.2.2 Killed Vaccines
2.3 PRRS Vaccines Sales by Type
2.3.1 Global PRRS Vaccines Sales Market Share by Type (2020-2025)
2.3.2 Global PRRS Vaccines Revenue and Market Share by Type (2020-2025)
2.3.3 Global PRRS Vaccines Sale Price by Type (2020-2025)
2.4 PRRS Vaccines Segment by Application
2.4.1 Government Tender
2.4.2 Market Sales
2.5 PRRS Vaccines Sales by Application
2.5.1 Global PRRS Vaccines Sale Market Share by Application (2020-2025)
2.5.2 Global PRRS Vaccines Revenue and Market Share by Application (2020-2025)
2.5.3 Global PRRS Vaccines Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global PRRS Vaccines Breakdown Data by Company
3.1.1 Global PRRS Vaccines Annual Sales by Company (2020-2025)
3.1.2 Global PRRS Vaccines Sales Market Share by Company (2020-2025)
3.2 Global PRRS Vaccines Annual Revenue by Company (2020-2025)
3.2.1 Global PRRS Vaccines Revenue by Company (2020-2025)
3.2.2 Global PRRS Vaccines Revenue Market Share by Company (2020-2025)
3.3 Global PRRS Vaccines Sale Price by Company
3.4 Key Manufacturers PRRS Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers PRRS Vaccines Product Location Distribution
3.4.2 Players PRRS Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PRRS VACCINES BY GEOGRAPHIC REGION
4.1 World Historic PRRS Vaccines Market Size by Geographic Region (2020-2025)
4.1.1 Global PRRS Vaccines Annual Sales by Geographic Region (2020-2025)
4.1.2 Global PRRS Vaccines Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic PRRS Vaccines Market Size by Country/Region (2020-2025)
4.2.1 Global PRRS Vaccines Annual Sales by Country/Region (2020-2025)
4.2.2 Global PRRS Vaccines Annual Revenue by Country/Region (2020-2025)
4.3 Americas PRRS Vaccines Sales Growth
4.4 APAC PRRS Vaccines Sales Growth
4.5 Europe PRRS Vaccines Sales Growth
4.6 Middle East & Africa PRRS Vaccines Sales Growth
5 AMERICAS
5.1 Americas PRRS Vaccines Sales by Country
5.1.1 Americas PRRS Vaccines Sales by Country (2020-2025)
5.1.2 Americas PRRS Vaccines Revenue by Country (2020-2025)
5.2 Americas PRRS Vaccines Sales by Type (2020-2025)
5.3 Americas PRRS Vaccines Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC PRRS Vaccines Sales by Region
6.1.1 APAC PRRS Vaccines Sales by Region (2020-2025)
6.1.2 APAC PRRS Vaccines Revenue by Region (2020-2025)
6.2 APAC PRRS Vaccines Sales by Type (2020-2025)
6.3 APAC PRRS Vaccines Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe PRRS Vaccines by Country
7.1.1 Europe PRRS Vaccines Sales by Country (2020-2025)
7.1.2 Europe PRRS Vaccines Revenue by Country (2020-2025)
7.2 Europe PRRS Vaccines Sales by Type (2020-2025)
7.3 Europe PRRS Vaccines Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa PRRS Vaccines by Country
8.1.1 Middle East & Africa PRRS Vaccines Sales by Country (2020-2025)
8.1.2 Middle East & Africa PRRS Vaccines Revenue by Country (2020-2025)
8.2 Middle East & Africa PRRS Vaccines Sales by Type (2020-2025)
8.3 Middle East & Africa PRRS Vaccines Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of PRRS Vaccines
10.3 Manufacturing Process Analysis of PRRS Vaccines
10.4 Industry Chain Structure of PRRS Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 PRRS Vaccines Distributors
11.3 PRRS Vaccines Customer
12 WORLD FORECAST REVIEW FOR PRRS VACCINES BY GEOGRAPHIC REGION
12.1 Global PRRS Vaccines Market Size Forecast by Region
12.1.1 Global PRRS Vaccines Forecast by Region (2026-2031)
12.1.2 Global PRRS Vaccines Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global PRRS Vaccines Forecast by Type (2026-2031)
12.7 Global PRRS Vaccines Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 China Animal Husbandry Co., Ltd.
13.1.1 China Animal Husbandry Co., Ltd. Company Information
13.1.2 China Animal Husbandry Co., Ltd. PRRS Vaccines Product Portfolios and Specifications
13.1.3 China Animal Husbandry Co., Ltd. PRRS Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 China Animal Husbandry Co., Ltd. Main Business Overview
13.1.5 China Animal Husbandry Co., Ltd. Latest Developments
13.2 Boehringer Ingelheim
13.2.1 Boehringer Ingelheim Company Information
13.2.2 Boehringer Ingelheim PRRS Vaccines Product Portfolios and Specifications
13.2.3 Boehringer Ingelheim PRRS Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Boehringer Ingelheim Main Business Overview
13.2.5 Boehringer Ingelheim Latest Developments
13.3 MSD Animal Health
13.3.1 MSD Animal Health Company Information
13.3.2 MSD Animal Health PRRS Vaccines Product Portfolios and Specifications
13.3.3 MSD Animal Health PRRS Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 MSD Animal Health Main Business Overview
13.3.5 MSD Animal Health Latest Developments
13.4 Sinopharm Animal Health
13.4.1 Sinopharm Animal Health Company Information
13.4.2 Sinopharm Animal Health PRRS Vaccines Product Portfolios and Specifications
13.4.3 Sinopharm Animal Health PRRS Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Sinopharm Animal Health Main Business Overview
13.4.5 Sinopharm Animal Health Latest Developments
13.5 Ceva
13.5.1 Ceva Company Information
13.5.2 Ceva PRRS Vaccines Product Portfolios and Specifications
13.5.3 Ceva PRRS Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Ceva Main Business Overview
13.5.5 Ceva Latest Developments
13.6 Ruipu Biological
13.6.1 Ruipu Biological Company Information
13.6.2 Ruipu Biological PRRS Vaccines Product Portfolios and Specifications
13.6.3 Ruipu Biological PRRS Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Ruipu Biological Main Business Overview
13.6.5 Ruipu Biological Latest Developments
13.7 Qilu Animal Health
13.7.1 Qilu Animal Health Company Information
13.7.2 Qilu Animal Health PRRS Vaccines Product Portfolios and Specifications
13.7.3 Qilu Animal Health PRRS Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Qilu Animal Health Main Business Overview
13.7.5 Qilu Animal Health Latest Developments
13.8 Dahuanong
13.8.1 Dahuanong Company Information
13.8.2 Dahuanong PRRS Vaccines Product Portfolios and Specifications
13.8.3 Dahuanong PRRS Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Dahuanong Main Business Overview
13.8.5 Dahuanong Latest Developments
13.9 CAVAC
13.9.1 CAVAC Company Information
13.9.2 CAVAC PRRS Vaccines Product Portfolios and Specifications
13.9.3 CAVAC PRRS Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 CAVAC Main Business Overview
13.9.5 CAVAC Latest Developments
13.10 Komipharm
13.10.1 Komipharm Company Information
13.10.2 Komipharm PRRS Vaccines Product Portfolios and Specifications
13.10.3 Komipharm PRRS Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Komipharm Main Business Overview
13.10.5 Komipharm Latest Developments
13.11 Agrovet
13.11.1 Agrovet Company Information
13.11.2 Agrovet PRRS Vaccines Product Portfolios and Specifications
13.11.3 Agrovet PRRS Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Agrovet Main Business Overview
13.11.5 Agrovet Latest Developments
13.12 Bioveta
13.12.1 Bioveta Company Information
13.12.2 Bioveta PRRS Vaccines Product Portfolios and Specifications
13.12.3 Bioveta PRRS Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Bioveta Main Business Overview
13.12.5 Bioveta Latest Developments
13.13 Jinyu
13.13.1 Jinyu Company Information
13.13.2 Jinyu PRRS Vaccines Product Portfolios and Specifications
13.13.3 Jinyu PRRS Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Jinyu Main Business Overview
13.13.5 Jinyu Latest Developments
13.14 Phibro Animal Health
13.14.1 Phibro Animal Health Company Information
13.14.2 Phibro Animal Health PRRS Vaccines Product Portfolios and Specifications
13.14.3 Phibro Animal Health PRRS Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Phibro Animal Health Main Business Overview
13.14.5 Phibro Animal Health Latest Developments
13.15 Tiankang
13.15.1 Tiankang Company Information
13.15.2 Tiankang PRRS Vaccines Product Portfolios and Specifications
13.15.3 Tiankang PRRS Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Tiankang Main Business Overview
13.15.5 Tiankang Latest Developments
13.16 Zoetis
13.16.1 Zoetis Company Information
13.16.2 Zoetis PRRS Vaccines Product Portfolios and Specifications
13.16.3 Zoetis PRRS Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Zoetis Main Business Overview
13.16.5 Zoetis Latest Developments
13.17 Yongshun Biological
13.17.1 Yongshun Biological Company Information
13.17.2 Yongshun Biological PRRS Vaccines Product Portfolios and Specifications
13.17.3 Yongshun Biological PRRS Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Yongshun Biological Main Business Overview
13.17.5 Yongshun Biological Latest Developments
13.18 Pulike Biological
13.18.1 Pulike Biological Company Information
13.18.2 Pulike Biological PRRS Vaccines Product Portfolios and Specifications
13.18.3 Pulike Biological PRRS Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 Pulike Biological Main Business Overview
13.18.5 Pulike Biological Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global PRRS Vaccines Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for PRRS Vaccines by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for PRRS Vaccines by Country/Region, 2020, 2024 & 2031
2.2 PRRS Vaccines Segment by Type
2.2.1 Live Vaccines
2.2.2 Killed Vaccines
2.3 PRRS Vaccines Sales by Type
2.3.1 Global PRRS Vaccines Sales Market Share by Type (2020-2025)
2.3.2 Global PRRS Vaccines Revenue and Market Share by Type (2020-2025)
2.3.3 Global PRRS Vaccines Sale Price by Type (2020-2025)
2.4 PRRS Vaccines Segment by Application
2.4.1 Government Tender
2.4.2 Market Sales
2.5 PRRS Vaccines Sales by Application
2.5.1 Global PRRS Vaccines Sale Market Share by Application (2020-2025)
2.5.2 Global PRRS Vaccines Revenue and Market Share by Application (2020-2025)
2.5.3 Global PRRS Vaccines Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global PRRS Vaccines Breakdown Data by Company
3.1.1 Global PRRS Vaccines Annual Sales by Company (2020-2025)
3.1.2 Global PRRS Vaccines Sales Market Share by Company (2020-2025)
3.2 Global PRRS Vaccines Annual Revenue by Company (2020-2025)
3.2.1 Global PRRS Vaccines Revenue by Company (2020-2025)
3.2.2 Global PRRS Vaccines Revenue Market Share by Company (2020-2025)
3.3 Global PRRS Vaccines Sale Price by Company
3.4 Key Manufacturers PRRS Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers PRRS Vaccines Product Location Distribution
3.4.2 Players PRRS Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PRRS VACCINES BY GEOGRAPHIC REGION
4.1 World Historic PRRS Vaccines Market Size by Geographic Region (2020-2025)
4.1.1 Global PRRS Vaccines Annual Sales by Geographic Region (2020-2025)
4.1.2 Global PRRS Vaccines Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic PRRS Vaccines Market Size by Country/Region (2020-2025)
4.2.1 Global PRRS Vaccines Annual Sales by Country/Region (2020-2025)
4.2.2 Global PRRS Vaccines Annual Revenue by Country/Region (2020-2025)
4.3 Americas PRRS Vaccines Sales Growth
4.4 APAC PRRS Vaccines Sales Growth
4.5 Europe PRRS Vaccines Sales Growth
4.6 Middle East & Africa PRRS Vaccines Sales Growth
5 AMERICAS
5.1 Americas PRRS Vaccines Sales by Country
5.1.1 Americas PRRS Vaccines Sales by Country (2020-2025)
5.1.2 Americas PRRS Vaccines Revenue by Country (2020-2025)
5.2 Americas PRRS Vaccines Sales by Type (2020-2025)
5.3 Americas PRRS Vaccines Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC PRRS Vaccines Sales by Region
6.1.1 APAC PRRS Vaccines Sales by Region (2020-2025)
6.1.2 APAC PRRS Vaccines Revenue by Region (2020-2025)
6.2 APAC PRRS Vaccines Sales by Type (2020-2025)
6.3 APAC PRRS Vaccines Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe PRRS Vaccines by Country
7.1.1 Europe PRRS Vaccines Sales by Country (2020-2025)
7.1.2 Europe PRRS Vaccines Revenue by Country (2020-2025)
7.2 Europe PRRS Vaccines Sales by Type (2020-2025)
7.3 Europe PRRS Vaccines Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa PRRS Vaccines by Country
8.1.1 Middle East & Africa PRRS Vaccines Sales by Country (2020-2025)
8.1.2 Middle East & Africa PRRS Vaccines Revenue by Country (2020-2025)
8.2 Middle East & Africa PRRS Vaccines Sales by Type (2020-2025)
8.3 Middle East & Africa PRRS Vaccines Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of PRRS Vaccines
10.3 Manufacturing Process Analysis of PRRS Vaccines
10.4 Industry Chain Structure of PRRS Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 PRRS Vaccines Distributors
11.3 PRRS Vaccines Customer
12 WORLD FORECAST REVIEW FOR PRRS VACCINES BY GEOGRAPHIC REGION
12.1 Global PRRS Vaccines Market Size Forecast by Region
12.1.1 Global PRRS Vaccines Forecast by Region (2026-2031)
12.1.2 Global PRRS Vaccines Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global PRRS Vaccines Forecast by Type (2026-2031)
12.7 Global PRRS Vaccines Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 China Animal Husbandry Co., Ltd.
13.1.1 China Animal Husbandry Co., Ltd. Company Information
13.1.2 China Animal Husbandry Co., Ltd. PRRS Vaccines Product Portfolios and Specifications
13.1.3 China Animal Husbandry Co., Ltd. PRRS Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 China Animal Husbandry Co., Ltd. Main Business Overview
13.1.5 China Animal Husbandry Co., Ltd. Latest Developments
13.2 Boehringer Ingelheim
13.2.1 Boehringer Ingelheim Company Information
13.2.2 Boehringer Ingelheim PRRS Vaccines Product Portfolios and Specifications
13.2.3 Boehringer Ingelheim PRRS Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Boehringer Ingelheim Main Business Overview
13.2.5 Boehringer Ingelheim Latest Developments
13.3 MSD Animal Health
13.3.1 MSD Animal Health Company Information
13.3.2 MSD Animal Health PRRS Vaccines Product Portfolios and Specifications
13.3.3 MSD Animal Health PRRS Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 MSD Animal Health Main Business Overview
13.3.5 MSD Animal Health Latest Developments
13.4 Sinopharm Animal Health
13.4.1 Sinopharm Animal Health Company Information
13.4.2 Sinopharm Animal Health PRRS Vaccines Product Portfolios and Specifications
13.4.3 Sinopharm Animal Health PRRS Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Sinopharm Animal Health Main Business Overview
13.4.5 Sinopharm Animal Health Latest Developments
13.5 Ceva
13.5.1 Ceva Company Information
13.5.2 Ceva PRRS Vaccines Product Portfolios and Specifications
13.5.3 Ceva PRRS Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Ceva Main Business Overview
13.5.5 Ceva Latest Developments
13.6 Ruipu Biological
13.6.1 Ruipu Biological Company Information
13.6.2 Ruipu Biological PRRS Vaccines Product Portfolios and Specifications
13.6.3 Ruipu Biological PRRS Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Ruipu Biological Main Business Overview
13.6.5 Ruipu Biological Latest Developments
13.7 Qilu Animal Health
13.7.1 Qilu Animal Health Company Information
13.7.2 Qilu Animal Health PRRS Vaccines Product Portfolios and Specifications
13.7.3 Qilu Animal Health PRRS Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Qilu Animal Health Main Business Overview
13.7.5 Qilu Animal Health Latest Developments
13.8 Dahuanong
13.8.1 Dahuanong Company Information
13.8.2 Dahuanong PRRS Vaccines Product Portfolios and Specifications
13.8.3 Dahuanong PRRS Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Dahuanong Main Business Overview
13.8.5 Dahuanong Latest Developments
13.9 CAVAC
13.9.1 CAVAC Company Information
13.9.2 CAVAC PRRS Vaccines Product Portfolios and Specifications
13.9.3 CAVAC PRRS Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 CAVAC Main Business Overview
13.9.5 CAVAC Latest Developments
13.10 Komipharm
13.10.1 Komipharm Company Information
13.10.2 Komipharm PRRS Vaccines Product Portfolios and Specifications
13.10.3 Komipharm PRRS Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Komipharm Main Business Overview
13.10.5 Komipharm Latest Developments
13.11 Agrovet
13.11.1 Agrovet Company Information
13.11.2 Agrovet PRRS Vaccines Product Portfolios and Specifications
13.11.3 Agrovet PRRS Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Agrovet Main Business Overview
13.11.5 Agrovet Latest Developments
13.12 Bioveta
13.12.1 Bioveta Company Information
13.12.2 Bioveta PRRS Vaccines Product Portfolios and Specifications
13.12.3 Bioveta PRRS Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Bioveta Main Business Overview
13.12.5 Bioveta Latest Developments
13.13 Jinyu
13.13.1 Jinyu Company Information
13.13.2 Jinyu PRRS Vaccines Product Portfolios and Specifications
13.13.3 Jinyu PRRS Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Jinyu Main Business Overview
13.13.5 Jinyu Latest Developments
13.14 Phibro Animal Health
13.14.1 Phibro Animal Health Company Information
13.14.2 Phibro Animal Health PRRS Vaccines Product Portfolios and Specifications
13.14.3 Phibro Animal Health PRRS Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Phibro Animal Health Main Business Overview
13.14.5 Phibro Animal Health Latest Developments
13.15 Tiankang
13.15.1 Tiankang Company Information
13.15.2 Tiankang PRRS Vaccines Product Portfolios and Specifications
13.15.3 Tiankang PRRS Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Tiankang Main Business Overview
13.15.5 Tiankang Latest Developments
13.16 Zoetis
13.16.1 Zoetis Company Information
13.16.2 Zoetis PRRS Vaccines Product Portfolios and Specifications
13.16.3 Zoetis PRRS Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Zoetis Main Business Overview
13.16.5 Zoetis Latest Developments
13.17 Yongshun Biological
13.17.1 Yongshun Biological Company Information
13.17.2 Yongshun Biological PRRS Vaccines Product Portfolios and Specifications
13.17.3 Yongshun Biological PRRS Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Yongshun Biological Main Business Overview
13.17.5 Yongshun Biological Latest Developments
13.18 Pulike Biological
13.18.1 Pulike Biological Company Information
13.18.2 Pulike Biological PRRS Vaccines Product Portfolios and Specifications
13.18.3 Pulike Biological PRRS Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 Pulike Biological Main Business Overview
13.18.5 Pulike Biological Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. PRRS Vaccines Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. PRRS Vaccines Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Live Vaccines
Table 4. Major Players of Killed Vaccines
Table 5. Global PRRS Vaccines Sales by Type (2020-2025) & (K Units)
Table 6. Global PRRS Vaccines Sales Market Share by Type (2020-2025)
Table 7. Global PRRS Vaccines Revenue by Type (2020-2025) & ($ million)
Table 8. Global PRRS Vaccines Revenue Market Share by Type (2020-2025)
Table 9. Global PRRS Vaccines Sale Price by Type (2020-2025) & (USD/Unit)
Table 10. Global PRRS Vaccines Sale by Application (2020-2025) & (K Units)
Table 11. Global PRRS Vaccines Sale Market Share by Application (2020-2025)
Table 12. Global PRRS Vaccines Revenue by Application (2020-2025) & ($ million)
Table 13. Global PRRS Vaccines Revenue Market Share by Application (2020-2025)
Table 14. Global PRRS Vaccines Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global PRRS Vaccines Sales by Company (2020-2025) & (K Units)
Table 16. Global PRRS Vaccines Sales Market Share by Company (2020-2025)
Table 17. Global PRRS Vaccines Revenue by Company (2020-2025) & ($ millions)
Table 18. Global PRRS Vaccines Revenue Market Share by Company (2020-2025)
Table 19. Global PRRS Vaccines Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers PRRS Vaccines Producing Area Distribution and Sales Area
Table 21. Players PRRS Vaccines Products Offered
Table 22. PRRS Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global PRRS Vaccines Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global PRRS Vaccines Sales Market Share Geographic Region (2020-2025)
Table 27. Global PRRS Vaccines Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global PRRS Vaccines Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global PRRS Vaccines Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global PRRS Vaccines Sales Market Share by Country/Region (2020-2025)
Table 31. Global PRRS Vaccines Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global PRRS Vaccines Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas PRRS Vaccines Sales by Country (2020-2025) & (K Units)
Table 34. Americas PRRS Vaccines Sales Market Share by Country (2020-2025)
Table 35. Americas PRRS Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas PRRS Vaccines Sales by Type (2020-2025) & (K Units)
Table 37. Americas PRRS Vaccines Sales by Application (2020-2025) & (K Units)
Table 38. APAC PRRS Vaccines Sales by Region (2020-2025) & (K Units)
Table 39. APAC PRRS Vaccines Sales Market Share by Region (2020-2025)
Table 40. APAC PRRS Vaccines Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC PRRS Vaccines Sales by Type (2020-2025) & (K Units)
Table 42. APAC PRRS Vaccines Sales by Application (2020-2025) & (K Units)
Table 43. Europe PRRS Vaccines Sales by Country (2020-2025) & (K Units)
Table 44. Europe PRRS Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe PRRS Vaccines Sales by Type (2020-2025) & (K Units)
Table 46. Europe PRRS Vaccines Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa PRRS Vaccines Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa PRRS Vaccines Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa PRRS Vaccines Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa PRRS Vaccines Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of PRRS Vaccines
Table 52. Key Market Challenges & Risks of PRRS Vaccines
Table 53. Key Industry Trends of PRRS Vaccines
Table 54. PRRS Vaccines Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. PRRS Vaccines Distributors List
Table 57. PRRS Vaccines Customer List
Table 58. Global PRRS Vaccines Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global PRRS Vaccines Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas PRRS Vaccines Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas PRRS Vaccines Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC PRRS Vaccines Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC PRRS Vaccines Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe PRRS Vaccines Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe PRRS Vaccines Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa PRRS Vaccines Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa PRRS Vaccines Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global PRRS Vaccines Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global PRRS Vaccines Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global PRRS Vaccines Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global PRRS Vaccines Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. China Animal Husbandry Co., Ltd. Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 73. China Animal Husbandry Co., Ltd. PRRS Vaccines Product Portfolios and Specifications
Table 74. China Animal Husbandry Co., Ltd. PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. China Animal Husbandry Co., Ltd. Main Business
Table 76. China Animal Husbandry Co., Ltd. Latest Developments
Table 77. Boehringer Ingelheim Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 78. Boehringer Ingelheim PRRS Vaccines Product Portfolios and Specifications
Table 79. Boehringer Ingelheim PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Boehringer Ingelheim Main Business
Table 81. Boehringer Ingelheim Latest Developments
Table 82. MSD Animal Health Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 83. MSD Animal Health PRRS Vaccines Product Portfolios and Specifications
Table 84. MSD Animal Health PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. MSD Animal Health Main Business
Table 86. MSD Animal Health Latest Developments
Table 87. Sinopharm Animal Health Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 88. Sinopharm Animal Health PRRS Vaccines Product Portfolios and Specifications
Table 89. Sinopharm Animal Health PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Sinopharm Animal Health Main Business
Table 91. Sinopharm Animal Health Latest Developments
Table 92. Ceva Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 93. Ceva PRRS Vaccines Product Portfolios and Specifications
Table 94. Ceva PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Ceva Main Business
Table 96. Ceva Latest Developments
Table 97. Ruipu Biological Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 98. Ruipu Biological PRRS Vaccines Product Portfolios and Specifications
Table 99. Ruipu Biological PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Ruipu Biological Main Business
Table 101. Ruipu Biological Latest Developments
Table 102. Qilu Animal Health Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 103. Qilu Animal Health PRRS Vaccines Product Portfolios and Specifications
Table 104. Qilu Animal Health PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 105. Qilu Animal Health Main Business
Table 106. Qilu Animal Health Latest Developments
Table 107. Dahuanong Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 108. Dahuanong PRRS Vaccines Product Portfolios and Specifications
Table 109. Dahuanong PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Dahuanong Main Business
Table 111. Dahuanong Latest Developments
Table 112. CAVAC Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 113. CAVAC PRRS Vaccines Product Portfolios and Specifications
Table 114. CAVAC PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 115. CAVAC Main Business
Table 116. CAVAC Latest Developments
Table 117. Komipharm Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 118. Komipharm PRRS Vaccines Product Portfolios and Specifications
Table 119. Komipharm PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 120. Komipharm Main Business
Table 121. Komipharm Latest Developments
Table 122. Agrovet Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 123. Agrovet PRRS Vaccines Product Portfolios and Specifications
Table 124. Agrovet PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 125. Agrovet Main Business
Table 126. Agrovet Latest Developments
Table 127. Bioveta Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 128. Bioveta PRRS Vaccines Product Portfolios and Specifications
Table 129. Bioveta PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 130. Bioveta Main Business
Table 131. Bioveta Latest Developments
Table 132. Jinyu Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 133. Jinyu PRRS Vaccines Product Portfolios and Specifications
Table 134. Jinyu PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 135. Jinyu Main Business
Table 136. Jinyu Latest Developments
Table 137. Phibro Animal Health Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 138. Phibro Animal Health PRRS Vaccines Product Portfolios and Specifications
Table 139. Phibro Animal Health PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 140. Phibro Animal Health Main Business
Table 141. Phibro Animal Health Latest Developments
Table 142. Tiankang Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 143. Tiankang PRRS Vaccines Product Portfolios and Specifications
Table 144. Tiankang PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 145. Tiankang Main Business
Table 146. Tiankang Latest Developments
Table 147. Zoetis Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 148. Zoetis PRRS Vaccines Product Portfolios and Specifications
Table 149. Zoetis PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 150. Zoetis Main Business
Table 151. Zoetis Latest Developments
Table 152. Yongshun Biological Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 153. Yongshun Biological PRRS Vaccines Product Portfolios and Specifications
Table 154. Yongshun Biological PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 155. Yongshun Biological Main Business
Table 156. Yongshun Biological Latest Developments
Table 157. Pulike Biological Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 158. Pulike Biological PRRS Vaccines Product Portfolios and Specifications
Table 159. Pulike Biological PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 160. Pulike Biological Main Business
Table 161. Pulike Biological Latest Developments
Table 1. PRRS Vaccines Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. PRRS Vaccines Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Live Vaccines
Table 4. Major Players of Killed Vaccines
Table 5. Global PRRS Vaccines Sales by Type (2020-2025) & (K Units)
Table 6. Global PRRS Vaccines Sales Market Share by Type (2020-2025)
Table 7. Global PRRS Vaccines Revenue by Type (2020-2025) & ($ million)
Table 8. Global PRRS Vaccines Revenue Market Share by Type (2020-2025)
Table 9. Global PRRS Vaccines Sale Price by Type (2020-2025) & (USD/Unit)
Table 10. Global PRRS Vaccines Sale by Application (2020-2025) & (K Units)
Table 11. Global PRRS Vaccines Sale Market Share by Application (2020-2025)
Table 12. Global PRRS Vaccines Revenue by Application (2020-2025) & ($ million)
Table 13. Global PRRS Vaccines Revenue Market Share by Application (2020-2025)
Table 14. Global PRRS Vaccines Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global PRRS Vaccines Sales by Company (2020-2025) & (K Units)
Table 16. Global PRRS Vaccines Sales Market Share by Company (2020-2025)
Table 17. Global PRRS Vaccines Revenue by Company (2020-2025) & ($ millions)
Table 18. Global PRRS Vaccines Revenue Market Share by Company (2020-2025)
Table 19. Global PRRS Vaccines Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers PRRS Vaccines Producing Area Distribution and Sales Area
Table 21. Players PRRS Vaccines Products Offered
Table 22. PRRS Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global PRRS Vaccines Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global PRRS Vaccines Sales Market Share Geographic Region (2020-2025)
Table 27. Global PRRS Vaccines Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global PRRS Vaccines Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global PRRS Vaccines Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global PRRS Vaccines Sales Market Share by Country/Region (2020-2025)
Table 31. Global PRRS Vaccines Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global PRRS Vaccines Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas PRRS Vaccines Sales by Country (2020-2025) & (K Units)
Table 34. Americas PRRS Vaccines Sales Market Share by Country (2020-2025)
Table 35. Americas PRRS Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas PRRS Vaccines Sales by Type (2020-2025) & (K Units)
Table 37. Americas PRRS Vaccines Sales by Application (2020-2025) & (K Units)
Table 38. APAC PRRS Vaccines Sales by Region (2020-2025) & (K Units)
Table 39. APAC PRRS Vaccines Sales Market Share by Region (2020-2025)
Table 40. APAC PRRS Vaccines Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC PRRS Vaccines Sales by Type (2020-2025) & (K Units)
Table 42. APAC PRRS Vaccines Sales by Application (2020-2025) & (K Units)
Table 43. Europe PRRS Vaccines Sales by Country (2020-2025) & (K Units)
Table 44. Europe PRRS Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe PRRS Vaccines Sales by Type (2020-2025) & (K Units)
Table 46. Europe PRRS Vaccines Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa PRRS Vaccines Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa PRRS Vaccines Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa PRRS Vaccines Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa PRRS Vaccines Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of PRRS Vaccines
Table 52. Key Market Challenges & Risks of PRRS Vaccines
Table 53. Key Industry Trends of PRRS Vaccines
Table 54. PRRS Vaccines Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. PRRS Vaccines Distributors List
Table 57. PRRS Vaccines Customer List
Table 58. Global PRRS Vaccines Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global PRRS Vaccines Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas PRRS Vaccines Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas PRRS Vaccines Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC PRRS Vaccines Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC PRRS Vaccines Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe PRRS Vaccines Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe PRRS Vaccines Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa PRRS Vaccines Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa PRRS Vaccines Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global PRRS Vaccines Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global PRRS Vaccines Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global PRRS Vaccines Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global PRRS Vaccines Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. China Animal Husbandry Co., Ltd. Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 73. China Animal Husbandry Co., Ltd. PRRS Vaccines Product Portfolios and Specifications
Table 74. China Animal Husbandry Co., Ltd. PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. China Animal Husbandry Co., Ltd. Main Business
Table 76. China Animal Husbandry Co., Ltd. Latest Developments
Table 77. Boehringer Ingelheim Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 78. Boehringer Ingelheim PRRS Vaccines Product Portfolios and Specifications
Table 79. Boehringer Ingelheim PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Boehringer Ingelheim Main Business
Table 81. Boehringer Ingelheim Latest Developments
Table 82. MSD Animal Health Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 83. MSD Animal Health PRRS Vaccines Product Portfolios and Specifications
Table 84. MSD Animal Health PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. MSD Animal Health Main Business
Table 86. MSD Animal Health Latest Developments
Table 87. Sinopharm Animal Health Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 88. Sinopharm Animal Health PRRS Vaccines Product Portfolios and Specifications
Table 89. Sinopharm Animal Health PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Sinopharm Animal Health Main Business
Table 91. Sinopharm Animal Health Latest Developments
Table 92. Ceva Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 93. Ceva PRRS Vaccines Product Portfolios and Specifications
Table 94. Ceva PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Ceva Main Business
Table 96. Ceva Latest Developments
Table 97. Ruipu Biological Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 98. Ruipu Biological PRRS Vaccines Product Portfolios and Specifications
Table 99. Ruipu Biological PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Ruipu Biological Main Business
Table 101. Ruipu Biological Latest Developments
Table 102. Qilu Animal Health Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 103. Qilu Animal Health PRRS Vaccines Product Portfolios and Specifications
Table 104. Qilu Animal Health PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 105. Qilu Animal Health Main Business
Table 106. Qilu Animal Health Latest Developments
Table 107. Dahuanong Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 108. Dahuanong PRRS Vaccines Product Portfolios and Specifications
Table 109. Dahuanong PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Dahuanong Main Business
Table 111. Dahuanong Latest Developments
Table 112. CAVAC Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 113. CAVAC PRRS Vaccines Product Portfolios and Specifications
Table 114. CAVAC PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 115. CAVAC Main Business
Table 116. CAVAC Latest Developments
Table 117. Komipharm Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 118. Komipharm PRRS Vaccines Product Portfolios and Specifications
Table 119. Komipharm PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 120. Komipharm Main Business
Table 121. Komipharm Latest Developments
Table 122. Agrovet Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 123. Agrovet PRRS Vaccines Product Portfolios and Specifications
Table 124. Agrovet PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 125. Agrovet Main Business
Table 126. Agrovet Latest Developments
Table 127. Bioveta Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 128. Bioveta PRRS Vaccines Product Portfolios and Specifications
Table 129. Bioveta PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 130. Bioveta Main Business
Table 131. Bioveta Latest Developments
Table 132. Jinyu Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 133. Jinyu PRRS Vaccines Product Portfolios and Specifications
Table 134. Jinyu PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 135. Jinyu Main Business
Table 136. Jinyu Latest Developments
Table 137. Phibro Animal Health Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 138. Phibro Animal Health PRRS Vaccines Product Portfolios and Specifications
Table 139. Phibro Animal Health PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 140. Phibro Animal Health Main Business
Table 141. Phibro Animal Health Latest Developments
Table 142. Tiankang Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 143. Tiankang PRRS Vaccines Product Portfolios and Specifications
Table 144. Tiankang PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 145. Tiankang Main Business
Table 146. Tiankang Latest Developments
Table 147. Zoetis Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 148. Zoetis PRRS Vaccines Product Portfolios and Specifications
Table 149. Zoetis PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 150. Zoetis Main Business
Table 151. Zoetis Latest Developments
Table 152. Yongshun Biological Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 153. Yongshun Biological PRRS Vaccines Product Portfolios and Specifications
Table 154. Yongshun Biological PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 155. Yongshun Biological Main Business
Table 156. Yongshun Biological Latest Developments
Table 157. Pulike Biological Basic Information, PRRS Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 158. Pulike Biological PRRS Vaccines Product Portfolios and Specifications
Table 159. Pulike Biological PRRS Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 160. Pulike Biological Main Business
Table 161. Pulike Biological Latest Developments
LIST OF FIGURES
Figure 1. Picture of PRRS Vaccines
Figure 2. PRRS Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global PRRS Vaccines Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global PRRS Vaccines Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. PRRS Vaccines Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. PRRS Vaccines Sales Market Share by Country/Region (2024)
Figure 10. PRRS Vaccines Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Live Vaccines
Figure 12. Product Picture of Killed Vaccines
Figure 13. Global PRRS Vaccines Sales Market Share by Type in 2025
Figure 14. Global PRRS Vaccines Revenue Market Share by Type (2020-2025)
Figure 15. PRRS Vaccines Consumed in Government Tender
Figure 16. Global PRRS Vaccines Market: Government Tender (2020-2025) & (K Units)
Figure 17. PRRS Vaccines Consumed in Market Sales
Figure 18. Global PRRS Vaccines Market: Market Sales (2020-2025) & (K Units)
Figure 19. Global PRRS Vaccines Sale Market Share by Application (2024)
Figure 20. Global PRRS Vaccines Revenue Market Share by Application in 2025
Figure 21. PRRS Vaccines Sales by Company in 2025 (K Units)
Figure 22. Global PRRS Vaccines Sales Market Share by Company in 2025
Figure 23. PRRS Vaccines Revenue by Company in 2025 ($ millions)
Figure 24. Global PRRS Vaccines Revenue Market Share by Company in 2025
Figure 25. Global PRRS Vaccines Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global PRRS Vaccines Revenue Market Share by Geographic Region in 2025
Figure 27. Americas PRRS Vaccines Sales 2020-2025 (K Units)
Figure 28. Americas PRRS Vaccines Revenue 2020-2025 ($ millions)
Figure 29. APAC PRRS Vaccines Sales 2020-2025 (K Units)
Figure 30. APAC PRRS Vaccines Revenue 2020-2025 ($ millions)
Figure 31. Europe PRRS Vaccines Sales 2020-2025 (K Units)
Figure 32. Europe PRRS Vaccines Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa PRRS Vaccines Sales 2020-2025 (K Units)
Figure 34. Middle East & Africa PRRS Vaccines Revenue 2020-2025 ($ millions)
Figure 35. Americas PRRS Vaccines Sales Market Share by Country in 2025
Figure 36. Americas PRRS Vaccines Revenue Market Share by Country (2020-2025)
Figure 37. Americas PRRS Vaccines Sales Market Share by Type (2020-2025)
Figure 38. Americas PRRS Vaccines Sales Market Share by Application (2020-2025)
Figure 39. United States PRRS Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada PRRS Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico PRRS Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil PRRS Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC PRRS Vaccines Sales Market Share by Region in 2025
Figure 44. APAC PRRS Vaccines Revenue Market Share by Region (2020-2025)
Figure 45. APAC PRRS Vaccines Sales Market Share by Type (2020-2025)
Figure 46. APAC PRRS Vaccines Sales Market Share by Application (2020-2025)
Figure 47. China PRRS Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan PRRS Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea PRRS Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia PRRS Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 51. India PRRS Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia PRRS Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 53. China Taiwan PRRS Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe PRRS Vaccines Sales Market Share by Country in 2025
Figure 55. Europe PRRS Vaccines Revenue Market Share by Country (2020-2025)
Figure 56. Europe PRRS Vaccines Sales Market Share by Type (2020-2025)
Figure 57. Europe PRRS Vaccines Sales Market Share by Application (2020-2025)
Figure 58. Germany PRRS Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 59. France PRRS Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 60. UK PRRS Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy PRRS Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia PRRS Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa PRRS Vaccines Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa PRRS Vaccines Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa PRRS Vaccines Sales Market Share by Application (2020-2025)
Figure 66. Egypt PRRS Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa PRRS Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel PRRS Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey PRRS Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries PRRS Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of PRRS Vaccines in 2025
Figure 72. Manufacturing Process Analysis of PRRS Vaccines
Figure 73. Industry Chain Structure of PRRS Vaccines
Figure 74. Channels of Distribution
Figure 75. Global PRRS Vaccines Sales Market Forecast by Region (2026-2031)
Figure 76. Global PRRS Vaccines Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global PRRS Vaccines Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global PRRS Vaccines Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global PRRS Vaccines Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global PRRS Vaccines Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of PRRS Vaccines
Figure 2. PRRS Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global PRRS Vaccines Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global PRRS Vaccines Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. PRRS Vaccines Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. PRRS Vaccines Sales Market Share by Country/Region (2024)
Figure 10. PRRS Vaccines Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Live Vaccines
Figure 12. Product Picture of Killed Vaccines
Figure 13. Global PRRS Vaccines Sales Market Share by Type in 2025
Figure 14. Global PRRS Vaccines Revenue Market Share by Type (2020-2025)
Figure 15. PRRS Vaccines Consumed in Government Tender
Figure 16. Global PRRS Vaccines Market: Government Tender (2020-2025) & (K Units)
Figure 17. PRRS Vaccines Consumed in Market Sales
Figure 18. Global PRRS Vaccines Market: Market Sales (2020-2025) & (K Units)
Figure 19. Global PRRS Vaccines Sale Market Share by Application (2024)
Figure 20. Global PRRS Vaccines Revenue Market Share by Application in 2025
Figure 21. PRRS Vaccines Sales by Company in 2025 (K Units)
Figure 22. Global PRRS Vaccines Sales Market Share by Company in 2025
Figure 23. PRRS Vaccines Revenue by Company in 2025 ($ millions)
Figure 24. Global PRRS Vaccines Revenue Market Share by Company in 2025
Figure 25. Global PRRS Vaccines Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global PRRS Vaccines Revenue Market Share by Geographic Region in 2025
Figure 27. Americas PRRS Vaccines Sales 2020-2025 (K Units)
Figure 28. Americas PRRS Vaccines Revenue 2020-2025 ($ millions)
Figure 29. APAC PRRS Vaccines Sales 2020-2025 (K Units)
Figure 30. APAC PRRS Vaccines Revenue 2020-2025 ($ millions)
Figure 31. Europe PRRS Vaccines Sales 2020-2025 (K Units)
Figure 32. Europe PRRS Vaccines Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa PRRS Vaccines Sales 2020-2025 (K Units)
Figure 34. Middle East & Africa PRRS Vaccines Revenue 2020-2025 ($ millions)
Figure 35. Americas PRRS Vaccines Sales Market Share by Country in 2025
Figure 36. Americas PRRS Vaccines Revenue Market Share by Country (2020-2025)
Figure 37. Americas PRRS Vaccines Sales Market Share by Type (2020-2025)
Figure 38. Americas PRRS Vaccines Sales Market Share by Application (2020-2025)
Figure 39. United States PRRS Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada PRRS Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico PRRS Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil PRRS Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC PRRS Vaccines Sales Market Share by Region in 2025
Figure 44. APAC PRRS Vaccines Revenue Market Share by Region (2020-2025)
Figure 45. APAC PRRS Vaccines Sales Market Share by Type (2020-2025)
Figure 46. APAC PRRS Vaccines Sales Market Share by Application (2020-2025)
Figure 47. China PRRS Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan PRRS Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea PRRS Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia PRRS Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 51. India PRRS Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia PRRS Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 53. China Taiwan PRRS Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe PRRS Vaccines Sales Market Share by Country in 2025
Figure 55. Europe PRRS Vaccines Revenue Market Share by Country (2020-2025)
Figure 56. Europe PRRS Vaccines Sales Market Share by Type (2020-2025)
Figure 57. Europe PRRS Vaccines Sales Market Share by Application (2020-2025)
Figure 58. Germany PRRS Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 59. France PRRS Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 60. UK PRRS Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy PRRS Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia PRRS Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa PRRS Vaccines Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa PRRS Vaccines Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa PRRS Vaccines Sales Market Share by Application (2020-2025)
Figure 66. Egypt PRRS Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa PRRS Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel PRRS Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey PRRS Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries PRRS Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of PRRS Vaccines in 2025
Figure 72. Manufacturing Process Analysis of PRRS Vaccines
Figure 73. Industry Chain Structure of PRRS Vaccines
Figure 74. Channels of Distribution
Figure 75. Global PRRS Vaccines Sales Market Forecast by Region (2026-2031)
Figure 76. Global PRRS Vaccines Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global PRRS Vaccines Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global PRRS Vaccines Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global PRRS Vaccines Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global PRRS Vaccines Revenue Market Share Forecast by Application (2026-2031)
